Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspect Medical to initiate BRITE trial

This article was originally published in The Gray Sheet

Executive Summary

375-patient, 9-center BRITE-MD (Biomarkers for Rapid Identification of Treatment Efficacy-Major Depression) trial begins enrollment in the U.S., with expected trial completion in June 2007. The firm's brain assessment technology, which predicts the effectiveness of antidepressants by analyzing electrical activity in the brain, will be used on patients from 21 to 75 years of age in the trial. According to Aspect, the new technology could help to reduce the number of rounds of pharmaceutical treatment a patient must endure prior to finding an efficacious antidepressant. Prior research by the firm showed that the technology predicted response to antidepressants with more than 80% accuracy (1"The Gray Sheet" Nov. 7, 2005, p. 16)...
Advertisement

Related Content

Aspect Medical Hopes To Pick Up Momentum From Anesthesia Group’s Ruling
Aspect Medical Hopes To Pick Up Momentum From Anesthesia Group’s Ruling
Advertisement
UsernamePublicRestriction

Register

MT023379

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel